DOW JONES21,413.44+469.93 2.24%
S&P 5002,526.90+56.40 2.28%
NASDAQ7,487.31+126.73 1.72%

H.C. Wainwright Maintains Buy on Acceleron Pharma, Lowers Price Target to $128

H.C. Wainwright maintains Acceleron Pharma (NASDAQ:XLRN) with a Buy and lowers the price target from $129 to $128.

Benzinga · 03/10/2020 11:35

H.C. Wainwright maintains Acceleron Pharma (NASDAQ:XLRN) with a Buy and lowers the price target from $129 to $128.